Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 11/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.37 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.35 |
| ▸ | PKM | P14618 | 2/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8464466 | 0.87 | KDM4E (0.42) | KDM4ELMNAALDH1A1TDP1EPHX2 | |
| SCHEMBL4743500 | 0.80 | KDM4E (0.45) | KDM4ELMNAALDH1A1TDP1EPHX2 | |
| SCHEMBL29116614 | 0.79 | KDM4E (0.41) | KDM4ELMNAALDH1A1TDP1EPHX2 | |
| SCHEMBL10456276 | 0.78 | KDM4E (0.39) | KDM4ELMNAALDH1A1TDP1EPHX2 | |
| SCHEMBL4783612 | 0.77 | KDM4E (0.42) | KDM4ELMNAALDH1A1TDP1EPHX2 | |
| SCHEMBL23694121 | 0.77 | SLC6A12 (0.45) | KDM4ELMNAALDH1A1TDP1EPHX2 | |
| SCHEMBL75258 | 0.77 | SLC6A12 (0.45) | KDM4ELMNAALDH1A1TDP1EPHX2 | |
| SCHEMBL1787909 | 0.77 | SLC6A12 (0.45) | KDM4ELMNAALDH1A1TDP1EPHX2 | |
| SCHEMBL560786 | 0.77 | SLC6A12 (0.45) | KDM4ELMNAALDH1A1TDP1EPHX2 | |
| SCHEMBL3760676 | 0.77 | KDM4E (0.47) | KDM4ELMNAALDH1A1TDP1EPHX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6753127-B2 | USING MIXTURE OF NORBORNENE POLYMER, ACID GENERATOR AND SOLVENT; PREBAKING, EXPOSURE TO RADIATION | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2004-06-22 | — | — | US | disclosed |
| US-20030118933-A1 | Norbornene-based copolymer for photoresist, preparation method thereof, and photoresist composition comprising the same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2003-06-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030118933-A1 | Norbornene-based copolymer for photoresist, preparation method thereof, and photoresist composition comprising the same | ARF1, PTK2, DNAJA1 | KDM4E 1889/4885LMNA 3594/4885ALDH1A1 410/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.